Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9008-67
Published February 21, 2024 · Recall initiated: January 25, 2024
Summary
FDA records drug Class III recall D-0321-2024, published February 21, 2024 and initiated January 25, 2024. Recalling firm: Teva Pharmaceuticals USA, Inc; Status: Ongoing; Reported quantity: 12,916 cartons; Lot: Lot #: 100042978, Exp 7/31/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
What to do
Voluntary: Firm initiated · Letter
Get an email if NORTREL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NORTREL
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Distributor
- nationwide
- Lot
- Lot #: 100042978, Exp 7/31/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen), packaged in cartons, eachFebruary 21, 2024
- FDAHydrALAZINE Hydrochloride Tablets, USP 10mg, packaged in 100-count (10x10 blister cards), Lot T04680, Rx only,February 21, 2024
- FDAVasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mLFebruary 21, 2024
- FDASpectral CT 7500: Software Version 5.0, Model 728333 and Spectral CT 7500 China: Software Version 5.0, ModelFebruary 14, 2024
- FDASpectral CT on Rails: Software Version 5.1.0.X, model 728334.February 14, 2024
- FDABubble Sensor (REF: 70105.5720)February 14, 2024
Questions about this recall
Was Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9008-67 recalled?
Yes. FDA published recall D-0321-2024 on February 21, 2024. Reported hazard: Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NORTREL.